Dr. Irshad M. Sulaiman has been involved in the area of biomedical research focusing on the control and prevention of human-pathogenic microorganisms for over three decades. He obtained his PhD from Delhi University. Dr. Sulaiman joined the U.S. CDC in 1997, and worked until 2008. Since 2008, he is with the U.S. FDA. He has characterized a large number of emerging infectious pathogens isolated from various sources of public health importance. He has developed several novel molecular diagnostic methods, described several new species and genotypes, and published 95 peer-reviewed manuscripts.

DIAGNOSIS OF HUMAN-PATHOGENIC GRAM-NEGATIVE BACTERIA. Recent Advancement in the Diagnosis of Cronobacter Species and Related Species Causing Foodborne Disease and Outbreaks. Current Practices for Isolation, Identification and Characterization of Campylobacter in Foods and Recommendations for Future. DIAGNOSIS OF HUMAN-PATHOGENIC GRAM-POSITIVE BACTERIA. Detection of Listeria monocytogenes in Food and Environment. Diagnosis of Human-Pathogenic Staphylococcus in Surveillance and Outbreak Detection. DIAGNOSIS OF HUMAN-PATHOGENIC VIRUS. Advances and Opportunities in Hepatitis B Virus and Hepatitis C Virus Diagnostics. DIAGNOSIS OF HUMAN-PATHOGENIC GASTROINTESTINAL PARASITES. Molecular Diagnosis of Intestinal Amebiasis. Recent Developments in the Diagnosis and Detection of the Zoonotic Parasite Toxoplasma gondii Causing Foodborne Disease and Outbreaks. Biology and Epidemiology of Cyclospora cayetanensis. Advances in the Detection and Diagnosis of Coccidian Parasites Causing Gastrointestinal Disease and Foodborne Outbreaks.